US-based · ISO 17025 Accredited Lab · Verify any COA by ID →
Results to date · Updated September 2026

Half of every sample tested
was not what the label said.

Tested at an ISO 17025 accredited US lab. Every result below is verifiable by COA ID.

0%
Failed to meet
label claim
0%
Contained none of
the labelled compound
0%
Met label claim
RetatrutideTirzepatideTesamorelinMOTS-cSS-31PinealonSemaxCJC-1295Ipamorelin5-Amino-1MQ RetatrutideTirzepatideTesamorelinMOTS-cSS-31PinealonSemaxCJC-1295Ipamorelin5-Amino-1MQ
What the data shows

Three results.

Nothing in it. A fifth of what it claimed. Exactly as sold. All three looked identical.

Not detected
0 mg

Sold as CJC-1295 / Ipamorelin

Neither peptide was detected. Not degraded, not underdosed — absent.

Verify CP-2026-63838 →
Underdosed
19.7%

Sold as 50 mg of 5-Amino-1MQ

Contained 9.84 mg. Correct compound, above 99% pure, four fifths of the dose missing.

Verify CP-2026-63852 →
Met claim
>99%

Sold as 30 mg of Retatrutide

Contained 30.66 mg at above 99% purity. Good product exists. You just cannot spot it.

Verify CP-2026-67892 →

Method

Purity by RP-HPLC. Identity by retention time concordance against a certified reference standard, per USP <621>. Quantity against an external standard curve. Analysis at an ISO 17025 accredited, FDA-registered, DEA-licensed US lab.

Figures cover 12 samples to date, updated as results return. Samples are customer-submitted, not randomly sampled — this is what we measured, not a market-wide rate.

You cannot tell by looking at the vial.

A third of these samples contained none of the compound they were sold as. Every one arrived as normal powder in a sealed, labelled vial.

The only way to know is to measure it.

Test Your Compound →